Patent Assignment
Reel/Frame 036242/0306
Assignment of Assignor's Interest
Recorded: 2015-07-31
Pages: 30
Assignors
GLASS, LAWRENCE IRWIN
Executed: 2013-12-11
BICKERDIKE, MICHAEL JOHN
Executed: 2012-11-21
SNAPE, MICHAEL FREDERICK
Executed: 2013-11-21
DE COGRAM, PATRICIA PEREZ
Executed: 2014-01-20
Assignee
NEUREN PHARMACEUTICALS LIMITED
697 BURKE ROAD, SUITE 201, CAMBERWELL, VIC 3124, NEW ZEALAND
Covered Properties
(3)
Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methyl Prolyl Glutamic Acid
PCT:
PCT/US2013/072049 ↗
Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methylprolyl-L-Glumatic Acid
Application:
14/602,600 →
Publication:
US 2015/0224164
Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methyl Prolyl Glutamic Acid
Application:
61/730,829 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 21, 2014
From: GLASS, LAWRENCE IRWIN; BICKERDIKE, MICHAEL JOHN; SNAPE, MICHAEL FREDERICK; DE COGRAM, PATRICIA PEREZ
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 032111/0430 →
Change of Address
Jan 21, 2014
From: NEUREN PHARMACEUTICALS LIMITED
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 032111/0850 →